Terms: = Liver cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
1309 results:
1. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer.
Raymant M; Astuti Y; Alvaro-Espinosa L; Green D; Quaranta V; Bellomo G; Glenn M; Chandran-Gorner V; Palmer DH; Halloran C; Ghaneh P; Henderson NC; Morton JP; Valiente M; Mielgo A; Schmid MC
Nat Commun; 2024 Apr; 15(1):3593. PubMed ID: 38678021
[TBL] [Abstract] [Full Text] [Related]
2. Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs.
Wei Q; Luo S; He G
Sci Rep; 2024 Apr; 14(1):9128. PubMed ID: 38644382
[TBL] [Abstract] [Full Text] [Related]
3. A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Zhu W; Zhang Z; Chen J; Chen X; Huang L; Zhang X; Huang X; Ma N; Xu W; Yi X; Lu X; Fu X; Li S; Mo G; Wang Y; Yuan G; Zang M; Li Q; Jiang X; He Y; Wu S; He Y; Li Y; Hou J
Signal Transduct Target Ther; 2024 Apr; 9(1):101. PubMed ID: 38643203
[TBL] [Abstract] [Full Text] [Related]
4. Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins.
Stone ML; Lee J; Lee JW; Coho H; Tariveranmoshabad M; Wattenberg MM; Choi H; Herrera VM; Xue Y; Choi-Bose S; Zingone SK; Patel D; Markowitz K; Delman D; Balachandran VP; Beatty GL
Nat Immunol; 2024 May; 25(5):755-763. PubMed ID: 38641718
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
[TBL] [Abstract] [Full Text] [Related]
6. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via stat3/CD155 signaling axis.
Chen J; Sun S; Li H; Cai X; Wan C
Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
[TBL] [Abstract] [Full Text] [Related]
7. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives.
Reyes-Hernández OD; Figueroa-González G; Quintas-Granados LI; Hernández-Parra H; Peña-Corona SI; Cortés H; Kipchakbayeva A; Mukazhanova Z; Habtemariam S; Leyva-Gómez G; Büsselberg D; Sharifi-Rad J
Drug Dev Res; 2024 Apr; 85(2):e22175. PubMed ID: 38567708
[TBL] [Abstract] [Full Text] [Related]
8. Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells.
Rouleau M; Villeneuve L; Allain EP; McCabe-Leroux J; Tremblay S; Nguyen Van Long F; Uchil A; Joly-Beauparlant C; Droit A; Guillemette C
BMC Cancer; 2024 Apr; 24(1):410. PubMed ID: 38566115
[TBL] [Abstract] [Full Text] [Related]
9. Exosomal lncRNA HEIH, an essential communicator for hepatocellular carcinoma cells and macrophage M2 polarization through the miR-98-5p/stat3 axis.
Ai JH; Wen YZ; Dai SJ; Zhang LD; Huang ZJ; Shi J
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23686. PubMed ID: 38549433
[TBL] [Abstract] [Full Text] [Related]
10. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/stat3 signaling: In vitro and in vivo therapeutic intervention.
He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
[TBL] [Abstract] [Full Text] [Related]
11. c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.
Mohan CD; Shanmugam MK; Gowda SGS; Chinnathambi A; Rangappa KS; Sethi G
Phytomedicine; 2024 Jun; 128():155379. PubMed ID: 38503157
[TBL] [Abstract] [Full Text] [Related]
12. Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/stat3 signal pathway.
Shi X; Lai Y; Liu W; Zhang X; Cang Y
Biochem Biophys Res Commun; 2024 Apr; 706():149758. PubMed ID: 38484571
[TBL] [Abstract] [Full Text] [Related]
13. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
Zhang ZG; Zhu HM; Hua HK
Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
[TBL] [Abstract] [Full Text] [Related]
14. Deciphering the Mechanism of Siwu Decoction Inhibiting liver Metastasis by Integrating Network Pharmacology and In Vivo Experimental Validation.
Chu X; Xie F; Hou C; Zhang X; Wang S; Xie H; An C; Li Y; Zhao L; Xue P; Zhu S
Integr Cancer Ther; 2024; 23():15347354241236205. PubMed ID: 38462929
[TBL] [Abstract] [Full Text] [Related]
15. Anti-proliferative Effects of Pinocembrin Isolated From
Saengboonmee C; Thithuan K; Mahalapbutr P; Taebprakhon C; Aman A; Rungrotmongkol T; Kamkaew A; Schevenels FT; Chompupong T; Wongkham S; Lekphrom R
Integr Cancer Ther; 2024; 23():15347354241237519. PubMed ID: 38462928
[TBL] [Abstract] [Full Text] [Related]
16. TGF-β1 induces PD-1 expression in macrophages through SMAD3/stat3 cooperative signaling in chronic inflammation.
Lei Z; Tang R; Wu Y; Mao C; Xue W; Shen J; Yu J; Wang X; Qi X; Wei C; Xu L; Zhu J; Li Y; Zhang X; Ye C; Chen X; Yang X; Zhou S; Su C
JCI Insight; 2024 Mar; 9(7):. PubMed ID: 38441961
[TBL] [Abstract] [Full Text] [Related]
17. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
18. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/stat3 signaling.
Xie S; Li X; Yan J; Yu H; Chen S; Chen K
Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977
[TBL] [Abstract] [Full Text] [Related]
19. Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma.
He M; Liu Y; Chen S; Deng H; Feng C; Qiao S; Chen Q; Hu Y; Chen H; Wang X; Jiang X; Xia X; Zhao M; Lyu N
Nat Commun; 2024 Feb; 15(1):1754. PubMed ID: 38409200
[TBL] [Abstract] [Full Text] [Related]
20. Network pharmacology analysis and experimental verification of the antitumor effect and molecular mechanism of isocryptomerin on HepG2 cells.
Cao JL; Li SM; Tang YJ; Hou WS; Wang AQ; Li TZ; Jin CH
Drug Dev Res; 2024 Apr; 85(2):e22165. PubMed ID: 38400652
[TBL] [Abstract] [Full Text] [Related]
[Next]
